Articles Referencing CLDX

GuruFocus

CLDX up 223%, Cohen Gains Big

With new drugs for brain cancer and breast cancer treatment nearing the end of clinical trials, Celldex Therapeutics Inc. ( CLDX ) is up 223% over the last 12 months. After increasing his... Read >>

GuruFocus

Steve Cohen Increases Celldex Up 145%

Sick of SEC and SAC? Here's a new thread that brings us back to what investing is all about. With its leading drug candidates for the treatment of brain cancer and breast cancer nearing the... Read >>

Zacks.com

Encouraging Data Presented by Gilead - Analyst Blog

Gilead Sciences, Inc. ( GILD ) recently presented encouraging data on its chronic angina drug Ranexa (ranolazine) from a phase IV study (TERISA: n=927). The TERISA (Type 2 Diabetes... Read >>

Zacks.com

Pharmacyclics to Sell Shares - Analyst Blog

Pharmacyclics, Inc. ( PCYC ) recently announced that it has initiated an underwritten public offering to sell 2.2 million shares of its common stock. The amount represents approximately... Read >>

Zacks.com

Santarus Tops, Focus on Zegerid - Analyst Blog

Santarus, Inc. ( SNTS ) reported fourth quarter 2012 earnings of 8 cents per share, well above the year-ago earnings of 3 cents per share and the Zacks Consensus Estimate of 1 cent per... Read >>

Zacks.com

Arena Cuts Loss, Misses Estimates - Analyst Blog

Arena Pharmaceuticals Inc.'s ( ARNA ) loss (excluding special items) of 10 cents per share in the fourth quarter of 2012 was narrower than the year-ago loss of 16 cents per share.  The... Read >>

Zacks.com

Good News for Gilead's HIV Pipeline - Analyst Blog

Gilead Sciences, Inc. ( GILD ) recently announced encouraging detailed 24-week data from a phase II study (study 102) on its HIV single tablet regimen (STR). The STR includes tenofovir... Read >>

NASDAQ.com News

Pre-Market Earnings Report for March 7, 2013 : CNQ, KR, BTE, SFD, NAV, JW/A, FGP, CIEN, EPL, PRIM, CMN, CLDX

The following companies are expected to report earnings prior to market open on 03/07/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Canadian Natural... Read >>

Zacks.com

JAZZ Beats EPS, Misses Sales - Analyst Blog

Jazz Pharmaceuticals plc ( JAZZ ) reported fourth quarter 2012 earnings (including share-based compensation charges but excluding other special items) of $1.38 per share, well above the... Read >>

Zacks.com

Celgene's Apremilast Encourages - Analyst Blog

Recently, Celgene Corporation ( CELG ) announced positive results on its candidate apremilast from a phase III study (ESTEEM 1), which evaluated patients suffering from moderate-to-severe... Read >>

NASDAQ.com News

Pre-Market Most Active for Feb 6, 2013 : ELN, QQQ, BAC, BBRY, ZNGA, NOK, GSK, VMED, KB, SNY, ARMH, CLDX

The NASDAQ 100 Pre-Market Indicator is down -4.58 to 2,750.41. The total Pre-Market volume is currently 6,114,936 shares traded. The following are the most active stocks for the pre-market... Read >>

NASDAQ.com News

Pre-Market Most Active for Dec 11, 2012 : AIG, BAC, HTZ, NOK, FB, HCA, GSK, SIRI, AAPL, URBN, QQQ, CLDX

The NASDAQ 100 Pre-Market Indicator is up 11.4 to 2,658.97. The total Pre-Market volume is currently 23,034,962 shares traded. The following are the most active stocks for the pre-market... Read >>

NASDAQ.com News

Pre-Market Earnings Report for August 10, 2012 : BAM, JCP, HAR, CYD, HSFT, CLDX, HZNP, SCR, XIN, URRE, HSKA, DLGC

The following companies are expected to report earnings prior to market open on 08/10/2012. Visit our Earnings Calendar for a full list of expected earnings releases. Brookfield Asset... Read >>

NASDAQ.com News

Pre-Market Most Active for May 24, 2012 : BAC, PPL, EMC, NTAP, HPQ, MTGE, CLDX, TS, FB, MT, QQQ, VOD

The NASDAQ 100 Pre-Market Indicator is up 3.27 to 2,550.35. The total Pre-Market volume is currently 5,525,288 shares traded. The following are the most active stocks for the... Read >>

NASDAQ.com News

After Hours Most Active for May 23, 2012 : NTAP, HPQ, BAC, BLK, IFSIA, QQQ, F, CLDX, KMI, PFE, ERIC, FB

The NASDAQ 100 After Hours Indicator is down -5.02 to 2,542.06. The total After hours volume is currently 33,125,344 shares traded. The following are the most active stocks for the... Read >>

Displaying 1-15 of 19
<< first < previous 1 2 next > last >>